ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 1107

$1.03M Total Retail Price of All Prescriptions

Rank: 90 out of 1107

490 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 12,468 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 723 470 1 2
OMEPRAZOLE 562 314 2 4
HYDROCODONE-ACETAMINOPHEN 560 306 S3 3 1
SIMVASTATIN 533 394 4 5
FUROSEMIDE 517 400 5 7
LEVOTHYROXINE SODIUM 500 376 6 3
METFORMIN HCL 441 286 7 8
POTASSIUM CHLORIDE 412 329 8 14
LOSARTAN POTASSIUM 363 265 9 29
AMLODIPINE BESYLATE 362 244 10 6
FLUOXETINE HCL 361 174 11 47
METOPROLOL TARTRATE 289 243 12 10
NEXIUM 260 166 13 18
CLOPIDOGREL 257 199 14 28
HYDROCHLOROTHIAZIDE 246 186 15 11
METOPROLOL SUCCINATE 243 191 16 16
ZOLPIDEM TARTRATE 230 138 17 22
GABAPENTIN 226 173 18 9
CRESTOR 213 139 19 23
PANTOPRAZOLE SODIUM 209 168 20 30
CARVEDILOL 185 153 21 27
LANTUS SOLOSTAR 184 136 22 129
CITALOPRAM HBR 168 120 23 17
RANITIDINE HCL 164 108 24 21
ALENDRONATE SODIUM 161 149 25 41
POLYETHYLENE GLYCOL 3350 153 133 26 46
GEMFIBROZIL 151 78 27 107
PREDNISONE 150 112 28 40
PLAVIX 149 107 29 39
ATENOLOL 143 124 30 19
ACETAMINOPHEN-CODEINE 143 91 S3 30 120
WARFARIN SODIUM 139 98 32 15
TAMSULOSIN HCL 136 92 33 30
DIGOXIN 133 116 34 52
ISOSORBIDE MONONITRATE ER 130 91 35 34
CIPROFLOXACIN HCL 127 111 36 59
AMLODIPINE BESYLATE-BENAZEPRIL 120 60 37 77
ATORVASTATIN CALCIUM 120 76 37 13
DONEPEZIL HCL 116 104 39 32
TRAMADOL HCL 113 75 40 26
LOSARTAN-HYDROCHLOROTHIAZIDE 111 100 41 66
PRAVASTATIN SODIUM 108 87 42 12
CYMBALTA 106 55 43 50
BYSTOLIC 106 78 43 138
ZETIA 105 78 45 76
RAMIPRIL 93 76 46 84
NAMENDA 92 87 47 42
NOVOLOG FLEXPEN 90 49 48 230
AMITRIPTYLINE HCL 85 49 R 49 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 69 50 24
PAROXETINE HCL 81 29 51 45
DILTIAZEM 24HR CD 79 62 52 126
HYDROXYZINE HCL 77 15 R 53 162
VENTOLIN HFA 77 18 53 97
SPIRONOLACTONE 76 66 55 72
CLONIDINE HCL 76 55 55 53
ONGLYZA 75 58 57 205
LEVOFLOXACIN 72 56 58 71
ALLOPURINOL 71 51 59 36
LYRICA 71 61 59 83
PROAIR HFA 71 43 59 37
SPIRIVA 70 40 62 57
CARBIDOPA-LEVODOPA 70 67 62 122
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 55 62 88
SERTRALINE HCL 69 56 65 20
CEPHALEXIN 69 49 65 81
LANTUS 68 39 67 49
OXYCODONE-ACETAMINOPHEN 67 59 S2 68 104
TRAZODONE HCL 66 15 69 33
TRILIPIX 66 26 69 153
TRICOR 66 47 69 95
CELEBREX 66 55 69 85
MIRTAZAPINE 65 46 73 61
LORAZEPAM 61 61 74 155
MELOXICAM 60 20 75 25
GLYBURIDE 60 49 R 75 68
METHYLPREDNISOLONE 59 41 77 119
LOVASTATIN 59 40 77 55
NIASPAN 59 42 77 125
LIPITOR 59 42 77 109
TOPIRAMATE 56 45 81 160
RISPERIDONE 55 31 82 79
FLUTICASONE PROPIONATE 55 51 82 38
CLOBETASOL PROPIONATE 54 34 84 323
QUETIAPINE FUMARATE 50 44 85 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.